Plasminogen activator inhibitor type-1 deficiency does not influence the outcome of murine pneumococcal pneumonia.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Blood

• Publication date

  2003-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD-2003-01-0227PMID 12702502
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alveolar macrophages have a protective antiinflammatory role during murine pneumococcal pneumonia.

  2003cited by this paper
• Urokinase Receptor Is Necessary for Adequate Host Defense Against Pneumococcal Pneumonia1

  2002cited by this paper
• TNF-α Compensates for the Impaired Host Defense of IL-1 Type I Receptor-Deficient Mice During Pneumococcal Pneumonia1

  2001cited by this paper
• PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction.

  2001cited by this paper
• Guidelines for treatment of community-acquired pneumonia.

  2001cited by this paper
• New functions of stromal proteases and their inhibitors in tumor progression.

  2001cited by this paper
• PAI-1, fibrosis, and the elusive provisional fibrin matrix.

  2000cited by this paper
• Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome.

  2000cited by this paper
• Coagulation abnormalities in acute lung injury and sepsis.

  2000cited by this paper
• Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults

  2000cited by this paper
• Urokinase Receptor-Deficient Mice Have Impaired Neutrophil Recruitment in Response to Pulmonary Pseudomonas aeruginosa Infection1

  2000cited by this paper
• Urokinase-Type Plasminogen Activator in Inflammatory Cell Recruitment and Host Defense against Pneumocystis carinii in Mice

  1999cited by this paper
• Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock.

  1999cited by this paper
• Commentary on the 1993 American Thoracic Society guidelines for the treatment of community-acquired pneumonia.

  1999cited by this paper
• Accuracy of ICD-9-CM codes in detecting community-acquired pneumococcal pneumonia for incidence and vaccine efficacy studies.

  1999cited by this paper
• 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group.

  1999cited by this paper
• Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages.

  1999cited by this paper
• Development and disease in proteinase-deficient mice: role of the plasminogen, matrix metalloproteinase and coagulation system.

  1998cited by this paper
• p55 Tumor Necrosis Factor Receptor Fusion Protein in the Treatment of Patients With Severe Sepsis and Septic Shock: A Randomized Controlled Multicenter Trial

  1997cited by this paper
• Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration.

  1997cited by this paper
• Cytokines in Host Defense against Pneumonia

  1997cited by this paper
• Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation.

  1997cited by this paper
• p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group.

  1997cited by this paper
• Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin.

  1997cited by this paper
• Plasminogen Activator Inhibitor-1 and Vitronectin Promote the Cellular Clearance of Thrombin by Low Density Lipoprotein Receptor-related Proteins 1 and 2 (*)

  1996cited by this paper
• Endogenously produced urokinase amplifies tumor necrosis factor‐α secretion by THP‐1 mononuclear phagocytes

  1996cited by this paper
• Increase of Plasminogen Activator Inhibitor Levels Predicts Outcome of Leukocytopenic Patients with Sepsis

  1996cited by this paper
• Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans. A murine transgenic model.

  1996cited by this paper
• The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock.

  1996cited by this paper
• Structural and Functional Analysis of the Plasminogen Activator Inhibitor-1 Binding Motif in the Somatomedin B Domain of Vitronectin*

  1996cited by this paper
• Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene.

  1996cited by this paper
• Differential expression of urokinase-type plasminogen activator, its receptor, and inhibitors in mouse skin after exposure to a tumor-promoting phorbol ester.

  1996cited by this paper
• Regulation of Integrin Function by the Urokinase Receptor

  1996cited by this paper
• Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group.

  1996cited by this paper
• Immunoassay of Murine t-PA, u-PA and PAI-1 Using Monoclonal Antibodies Raised in Gene-inactivated Mice

  1995cited by this paper
• Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice.

  1995cited by this paper
• Impact of urokinase-type plasminogen activator and its inhibitor type 1 on prognosis in cervical cancer of the uterus.

  1994cited by this paper
• Urokinase (uPA) and PAI-1 predict survival in advanced ovarian cancer patients (FIGO III) after radical surgery and platinum-based chemotherapy.

  1994cited by this paper
• Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue.

  1994cited by this paper
• Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer.

  1994cited by this paper
• Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis.

  1993cited by this paper
• Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization.

  1993cited by this paper
• Procoagulant and fibrinolytic activities in bronchoalveolar fluid of HIV-positive and HIV-negative patients.

  1992cited by this paper
• The plasminogen activator/plasmin system.

  1991cited by this paper
• Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo.

  1990cited by this paper
• Local activation of the coagulation and fibrinolysis systems in lung disease.

  1990cited by this paper
• Types 1 and 2 Plasminogen Activator lnhibitor and Tirmor Necrosis Factor Alpha in Fatients with Sepsis

  1990cited by this paper
• Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease.

  1990cited by this paper
• Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome.

  1990cited by this paper
• Plasminogen Activator Inhibitor 1: A New Prognostic Marker in Septic Shock

  1989cited by this paper
• Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome.

  1989cited by this paper
• Procoagulant and plasminogen activator activities of bronchoalveolar fluid in patients with pulmonary sarcoidosis.

  1988cited by this paper
• Plasminogen activator inhibitors.

  1987cited by this paper
• The Interaction of Activated Protein C and Thrombin with the Plasminogen Activator Inhibitor Released from Human Endothelial Cells

  1987cited by this paper
• Abnormalities in pathways of alveolar fibrin turnover among patients with interstitial lung disease.

  1986cited by this paper
• Quantitation of urokinase antigen in plasma and culture media by use of an ELISA.

  1986cited by this paper
• Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells.

  1984cited by this paper
• A Simple, Sensitive Spectrophotometric Assay for Extrinsic (Tissue-Type) Plasminogen Activator Applicable to Measurements in Plasma

  1982cited by this paper
• Infectious Diseases Society of America

  1969cited by this paper

• Critical roles of PAI-1 in lipopolysaccharide-induced acute lung injury.

  2024cites this paper
• PAI-1 as a critical factor in the resolution of sepsis and acute kidney injury in old age

  2024cites this paper
• Anemarrhena asphodeloides Bunge polysaccharides alleviate lipoteichoic acid-induced lung inflammation and modulate gut microbiota in mice

  2024cites this paper
• Plasminogen System in the Pathophysiology of Sepsis: Upcoming Biomarkers

  2023cites this paper
• Procoagulant Activity of Blood and Microvesicles Is Disturbed by Pneumococcal Pneumolysin, Which Interacts with Coagulation Factors

  2022cites this paper
• Diagnostic value of C-reactive protein and soluble urokinase plasminogen activator receptor in canine monocytic ehrlichiosis

  2021cites this paper
• Skin and soft tissue infections

  2021cites this paper
• TGF-β regulation of the uPA/uPAR axis modulates mesothelial-mesenchymal transition (MesoMT)

  2021cites this paper
• Réponse de l’endothélium microvasculaire à l’inflammation aiguë

  2020cites this paper
• Endothelial Responses in Sepsis.

  2020cites this paper
• Targeting coagulation activation in severe COVID-19 pneumonia: lessons from bacterial pneumonia and sepsis

  2020cites this paper
• Diagnostic Value of Serum Urokinase-Type Plasminogen Activator Receptor in Children With Acute Appendicitis.

  2018cites this paper
• The role of the intestinal microbiota in pneumonia and sepsis

  2017cites this paper
• The role of the intestinal microbiota in pneumonia and sepsis

  2017cites this paper
• Proteolysis of plasminogen activator inhibitor‐1 by Yersinia pestis remodulates the host environment to promote virulence

  2016cites this paper
• Plasminogen activator inhibitor‐1 does not contribute to the pulmonary pathology induced by acute exposure to ozone

  2016cites this paper
• Endogenous tissue factor pathway inhibitor has a limited effect on host defence in murine pneumococcal pneumonia

  2015cites this paper
• Protease Activated Receptor 4 limits bacterial growth and lung pathology during late stage Streptococcus pneumoniae induced pneumonia in mice

  2015cites this paper
• The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia

  2015cites this paper
• S8 – S47 and O50 – O440

  2015cites this paper
• The tissue factor pathway in pneumonia

  2015cites this paper
• ResearchActivated protein C ameliorates coagulopathy but does not influence outcome in lethal H 1 N 1 influenza : a controlled laboratory study

  2015cites this paper
• Feasibility and Safety of Local Treatment with Recombinant Human Tissue Factor Pathway Inhibitor in a Rat Model of Streptococcus pneumoniae Pneumonia

  2015cites this paper
• Systemic inhibition and liver‐specific over‐expression of PAI‐1 failed to improve survival in all‐inclusive populations or homogenous cohorts of CLP mice

  2014cites this paper
• Protease-activated receptor-1 impairs host defense in murine pneumococcal pneumonia

  2014cites this paper
• Coagulation and fibrinolysis in tuberculosis, melioidosis and beyond

  2014cites this paper
• University of Groningen Relative Tissue Factor Deficiency Attenuates Ventilator-Induced Coagulopathy but Does Not Protect against Ventilator-Induced Lung Injury in Mice Wolthuis,

  2014cites this paper
• The protein C system in severe infection

  2014cites this paper
• The in vivo and in vitro Roles of Epithelial Pattern Recognition Receptors in Pneumococcal Infections

  2014cites this paper
• The role of Serpine-1 and Tissue inhibitor of metalloproteinase type-1 in early host responses to Staphylococcus aureus intracutaneous infection of mice.

  2013cites this paper
• Gram-negative pneumonia Plasminogen activator inhibitor type 1 is protective during severe

  2013cites this paper
• Streptococcus pneumoniae Serine Protease HtrA, but Not SFP or PrtA, Is a Major Virulence Factor in Pneumonia

  2013cites this paper
• PAI-1 and IFN-γ in the regulation of innate immune homeostasis during sublethal yersiniosis.

  2013cites this paper
• Protease activated receptor 4 limits bacterial growth and lung pathology during late stage Streptococcus pneumoniae induced pneumonia in mice

  2013cites this paper
• Protease-activated receptor-1 impairs host defense in murine pneumococcal pneumonia: a controlled laboratory study

  2012cites this paper
• Bronchoalveolar Activation of Coagulation and Inhibition of Fibrinolysis during Ventilator-Associated Lung Injury

  2012cites this paper
• The urokinase-receptor in infectious diseases.

  2012cites this paper
• PAI‐1, progress in understanding the clinical problem and its aetiology

  2012cites this paper
• The urokinase-receptor in infectious diseases Il recettore dell'urochinasi nelle infezioni

  2012cites this paper
• Plasminogen activator inhibitor type-1 deficiency exaggerates LPS-induced acute lung injury through enhancing Toll-like receptor 4 signaling pathway

  2011cites this paper
• ROLE OF VITRONECTIN INTERACTION IN THE BIOLOGY OF THE UROKINASE RECEPTOR

  2011cites this paper
• CD44 is protective during hyperoxia-induced lung injury.

  2011cites this paper
• The urokinase receptor system, a key regulator at the intersection between inflammation, immunity, and coagulation.

  2011cites this paper
• The Effects of Pharmacologic Plasminogen Activator Inhibitor-1 Inhibition in Acute and Chronic Rejection in Murine Cardiac Allografts

  2011cites this paper
• Recombinant human tissue factor pathway inhibitor exerts anticoagulant, anti‐inflammatory and antimicrobial effects in murine pneumococcal pneumonia

  2011cites this paper
• PAI-1 is an essential component of the pulmonary host response during Pseudomonas aeruginosa pneumonia in mice

  2011cites this paper
• Recombinant activated protein C attenuates coagulopathy and inflammation when administered early in murine pneumococcal pneumonia

  2011cites this paper
• Plasminogen activator inhibitor type I contributes to protective immunity during experimental Gram‐negative sepsis (melioidosis)

  2011cites this paper
• THORAXJNL155788-200111 788..796

  2011cites this paper
• Relative Tissue Factor Deficiency Attenuates Ventilator-Induced Coagulopathy but Does Not Protect against Ventilator-Induced Lung Injury in Mice

  2011cites this paper
• Effects of specific chemical suppressors of plasminogen activator inhibitor-1 in cardiovascular diseases

  2011cites this paper
• Impact of endogenous protein C on pulmonary coagulation and injury during lethal H1N1 influenza in mice.

  2011cites this paper
• Impact of the factor V Leiden mutation on the outcome of pneumococcal pneumonia: a controlled laboratory study

  2010cites this paper
• Open Access RESEARCH

  2010cites this paper
• The role of CD 44 and osteopontin in infection and inflammation

  2010cites this paper
• Cardiovascular , Pulmonary and Renal Pathology Protease-Activated Receptor-2 Induces Myofibroblast Differentiation and Tissue Factor Up-Regulation during Bleomycin-Induced Lung Injury Potential Role in Pulmonary Fibrosis

  2010cites this paper
• Therapeutic recombinant murine activated protein C attenuates pulmonary coagulopathy and improves survival in murine pneumococcal pneumonia.

  2010cites this paper
• UvA-DARE ( Digital Academic Repository ) Immunotolerance during bacterial pneumonia and sepsis

  2010cites this paper
• Activation of coagulation and inhibition of fibrinolysis in the human lung on bronchial instillation of lipoteichoic acid and lipopolysaccharide*

  2009cites this paper
• 4G/5G Polymorphism of Plasminogen Activator Inhibitor -1 Gene Is Associated with Mortality in Intensive Care Unit Patients with Severe Pneumonia

  2009cites this paper
• of fibrinolysis in the human lung upon bronchial instillation of lipoteichoic acid and lipopolysaccharide

  2009cites this paper
• Neither fibrin nor plasminogen activator inhibitor-1 deficiency protects lung function in a mouse model of acute lung injury.

  2009cites this paper
• A review of pulmonary coagulopathy in acute lung injury, acute respiratory distress syndrome and pneumonia

  2009cites this paper
• Nosologie et prise en charge des gammapathies monoclonales.

  2009cites this paper
• Prevalence and Significance of Coagulation Abnormalities in Community-Acquired Pneumonia

  2009cites this paper
• Plasminogen activator inhibitor-1 regulates neutrophil influx during acute pyelonephritis.

  2009cites this paper
• Meta-analysis: convenient assumptions and inconvenient truth.

  2008cites this paper
• Role played by Toll-like receptors 2 and 4 in lipoteichoic acid-induced lung inflammation and coagulation.

  2008cites this paper
• Lung protective mechanical ventilation

  2008cites this paper
• Mechanical Ventilation with Lower Tidal Volumes and Positive End-expiratory Pressure Prevents Pulmonary Inflammation in Patients without Preexisting Lung Injury

  2008cites this paper
• Ventilator-induced coagulopathy in experimental Streptococcus pneumoniae pneumonia

  2008cites this paper
• Antithrombin inhibits bronchoalveolar activation of coagulation and limits lung injury during Streptococcus pneumoniae pneumonia in rats*

  2008cites this paper
• Intracellular and extracellular serpins modulate lung disease

  2008cites this paper
• A specific inhibitor of plasminogen activator inhibitor-1 suppresses rat autoimmune myocarditis

  2008cites this paper
• Treating lung infections with anticoagulation: mechanisms matter.

  2008cites this paper
• Transgenic tissue‐type plasminogen activator expression improves host defense during Klebsiella pneumonia

  2008cites this paper
• Gene Expression Profiles in Murine Influenza Pneumonia

  2008cites this paper
• Functional characterization of extracellular protease inhibitors of phytophthora SPP and their targets tomato proteases

  2007cites this paper
• Clinical and hemostatic responses to treatment in ventilator-associated pneumonia: Role of bacterial pathogens*

  2007cites this paper
• 4G/5G plasminogen activator inhibitor-1 polymorphisms and haplotypes are associated with pneumonia.

  2007cites this paper
• Salmeterol enhances pulmonary fibrinolysis in healthy volunteers

  2007cites this paper
• Tumor suppressor CYLD regulates acute lung injury in lethal Streptococcus pneumoniae infections.

  2007cites this paper
• Plasminogen activator inhibitor type 1 is protective during severe Gram-negative pneumonia.

  2007cites this paper
• Coagulation and anticoagulation in acute lung injury, pneumonia, and ventilator-associated lung injury

  2007influential citation
• Toll-like receptors and innate immunity in pneumonia

  2007cites this paper
• Fibrinolysis and host response in bacterial infections

  2007cites this paper
• factor-factor Vil a pathway in murinee pneumococcal pneumonia

  2007cites this paper
• Reduced sickle erythrocyte dehydration in vivo by endothelin-1 receptor antagonists.

  2007cites this paper
• Plasminogen activator inhibitor type 1 is protective during severe Gram-negative pneumonia against

  2007cites this paper
• Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia*

  2006cites this paper
• Involvement of the Urokinase Kringle Domain in Lipopolysaccharide-Induced Acute Lung Injury1

  2006cites this paper
• pneumoniain the lung during ventilator associated Local activation of coagulation and inhibition of

  2006cites this paper
• Smoldering multiple myeloma and monoclonal gammopathy of undetermined significance

  2006cites this paper
• Cellular and Molecular Aspects of Pneumonia

  2006cites this paper
• Acute Lung Injury Domain in Lipopolysaccharide-Induced Involvement of the Urokinase Kringle Cines

  2006cites this paper
• Mechanical Ventilation with Lower Tidal Volumes and Positive End-expiratory Pressure Prevents Alveolar Coagulation in Patients without Lung Injury

  2006cites this paper
• Effects on Coagulation and Fibrinolysis Induced by Influenza in Mice With a Reduced Capacity to Generate Activated Protein C and a Deficiency in Plasminogen Activator Inhibitor Type 1

  2006cites this paper
• Urokinase-type plasminogen activator, an endogenous antibiotic.

  2005cites this paper
• Regulation of Lipopolysaccharide-Induced Lung Inflammation by Plasminogen Activator Inhibitor-1 through a JNK-Mediated Pathway

  2005cites this paper
• Pulmonary coagulation and fibrinolysis in acute lung injury and pneumonia

  2005cites this paper